WJV  Vol.2 No.1 , February 2012
Achieving Polio Eradication: A Need for Innovative Strategies
Abstract: Objective: The objective of this study was to analyze the current strategies used for eradicating wild polio viruses (WPV) and to propose some innovative strategies that may help to accelerate the progress towards polio eradication. Methods: We assessed the current strategies proposed by the World Health Organization, and the effectiveness of the current trivalent oral polio vaccine types 1, 2 and 3 (tOPV) schedule. Results: With the current schedule, tOPV is given four times to the child during his first year of life. After the four doses, 27%, 10% and 30% of children vaccinated are not immunized against WPV types 1, 2 and 3 respectively. In addition, low access to health care, insufficient funding of the routine immunization activities, and weak health systems hamper the tOPV coverage and the early detection of WPV cases for a rapid outbreak response. All these issues could explain the recurrence of WPV outbreaks, even in countries free of polio for many years. Therefore, we propose for countries of non-polio free regions, a new routine polio vaccination schedule composed of four doses of tOPV, followed by three doses of monovalent OPV type 1, and lastly by three doses of bivalent OPV types 1 and 3. With this schedule, of children fully vaccinated, 100%, 90% and 99% will be immunized against WPV types 1, 2 and 3 respectively. In addition, adequate funding for routine immunization activities and health system strengthening are proposed to accelerate the achievement of the polio eradication goal in a near future. Conclusions: The polio eradication goal is achievable. However, innovative strategies are urgently needed to improve the effectiveness and the efficiency of the routine polio immunization program.
Cite this paper: B. Keugoung, R. Fotsing, B. Criel and J. Macq, "Achieving Polio Eradication: A Need for Innovative Strategies," World Journal of Vaccines, Vol. 2 No. 1, 2012, pp. 46-49. doi: 10.4236/wjv.2012.21006.

[1]   WHO, “Gobal Polio Eradication Initiative: History,” 2010.

[2]   WHO, “Global Polio Eradication Initiative: AFP/Polio Case Count,” 2011.

[3]   Lancet, “Innovation for Polio Eradication,” Lancet Infectious Diseases, Vol. 11, 2011, p. 721. doi:10.1016/S1473-3099(11)70258-4

[4]   N. C. Grassly, J. Wenger, S. Durrani, S. Bahl, J. M. Deshpande, R. W. Sutter, D. L. Heymann and R. B. Aylward, “Protective Efficacy of a Monovalent Oral Type 1 Poliovirus Vaccine: A Case-Control Study,” Lancet, Vol. 369, No. 9750, 2007, pp. 1356-1362. doi:10.1016/S0140-6736(07)60531-5

[5]   H. E. Jenkins, R. B. Aylward, A. Gasasira, C. A. Donnelly, E. A. Abanida, T. Koleosho-Adelakan and N. C. Grassly, “Effectiveness of Immunization against Paralytic Poliomyelitis in Nigeria,” The New England Journal of Medicine, Vol. 359, No. 16, 2008, pp. 1666-1674. doi:10.1056/NEJMoa0803259

[6]   S. Robertson, “Module 6: Poliomyelitis. The Immunological Basis for Immunization Series,” WHO, Geneva, 1993.

[7]   Y. Berhane, C. J. Clements, J. M. Ndiaye and P. Taylor, “Has Routine Immunisation in Africa Become Endangered?” Lancet, Vol. 9, No. 11, 2009, pp. 655-656. doi:10.1016/S1473-3099(09)70268-3

[8]   J. P. Unger, “Can Intensive Campaigns Dynamize Front Line Health Services? The Evaluation of an Immunization Campaigns in Thiès Health District, Senegal,” Social Sciences and Medicine, Vol. 32, No. 3, 1991, pp. 249-259. doi:10.1016/0277-9536(91)90101-H

[9]   A. Buve, S. Kalibala and J. McIntyre, “Stronger Health Systems for More Effective HIV/AIDS Prevention and Care,” International Journal of Health Planning and Management; Vol. 18, No. S1, 2003, pp. S41-S51. doi:10.1002/hpm.725

[10]   B. Keugoung, J. M. Macq, A. Buve, J. Meli and B. Criel, “The Interface between Health Systems and Vertical Programmes in Francophone Africa: The Managers’ Perceptions,” Tropical Medicine and International Health, Vol. 16, No. 4, 2011, pp. 478-485. doi:10.1111/j.1365-3156.2010.02716.x